促销时间表 NeuroPace, Inc.
先进的时间表
简单图表
关于公司
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. 更多详情| Цена ао | 13.33 |
|---|---|
| Выручка | 0.037 |
| EBITDA | -0.0201 |
| P/S | 5.46 |
| P/BV | 3.35 |
| EV/EBITDA | -2.92 |
| ISIN | US6412881053 |
| Сайт | https://www.neuropace.com |
| Число акций ао | 0.02585 млрд |
| Валюта | usd |
| IPO date | 2021-04-22 |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Валюта отчета | usd |
| 每日价格变化: | -0.9288% (6.46) |
|---|---|
| 每周价格变化: | +4.75% (6.11) |
| 每月价格变化: | -13.86% (7.43) |
| 3个月内价格变化: | -12.33% (7.3) |
| 六个月内的价格变化: | -54.22% (13.98) |
| 每年价格变化: | +4.07% (6.15) |
| 3年内价格变化: | -61.26% (16.52) |
| 年初以来价格变化: | -26.44% (8.7) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| KCK Limited | 5621111 | 21.39 |
| Orbimed Advisors LLC. | 4003967 | 15.23 |
| Morgan Stanley | 2460716 | 9.36 |
| Soleus Capital Management, L.P. | 2433168 | 9.26 |
| Nantahala Capital Management, LLC | 2347354 | 8.93 |
| Kent Lake Capital, LLC | 670946 | 2.55 |
| FMR, LLC | 468081 | 1.78 |
| Vanguard Group Inc | 413106 | 1.57 |
| Millennium Management LLC | 172403 | 0.66 |
| Geode Capital Management, LLC | 115996 | 0.44 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| ProShares Hedge Replication ETF | 0.00058 | 5.9237999659878 | 1.47892 |
| iShares Micro-Cap ETF | 0.02573 | 36.318555985322 | 1.54048 |
| iShares Russell 2000 Growth ETF | 0.00726 | 38.042556988 | 0.6026 |
| ProShares UltraPro Russell2000 | 0.0022 | 89.821266282945 | 1.47873 |
| Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 39.350070246167 | 0.60264 |
| Vanguard Russell 2000 ETF | 0 | 35.648084105685 | 1.48801 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Dr. Martha J. Morrell | Chief Medical Officer | 728.68k | 1957 (67 年) |
| Mr. Joel D. Becker | CEO, President & Director | 762k | 1968 (56 年) |
| Ms. Rebecca L. Kuhn | CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary | 614.91k | 1961 (63 年) |
| Ms. Kelley Nicholas | Vice President of Sales | N/A | |
| Ms. Leah Akin | Acting General Counsel | N/A | |
| Mr. Dylan St. John | Chief of Operations & Development |
地址: United States, Mountain View. CA, 455 North Bernardo Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.neuropace.com
网站: https://www.neuropace.com
